ℹ️ Compiled from public regulatory records · Last regulator revision: April 30, 2025🚩 Report this page
Potassium Phosphate
Active ingredient
Sold as K Phos Original · KALI PHOSPHORICUM · JetZone Jet Lag Prevention
US FDACA Health Canada
- Drug class
- -
- Availability
- Prescription and OTC
- Routes
- Intravenous, Oral
- Markets covered
- 2
- Products on record
- 5
- FDA reports (12 mo)
- 162
Overview
Potassium Phosphate is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 4 | April 30, 2025 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
USUnited States· FDA
4 products
Uses
INDICATIONS
Condition listed above or as directed by the physician
How to take
CACanada· Health Canada
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Sources & citations
- [1]FDA DailyMed · 074959bb-0638-4e… · revised September 27, 2021 [PDF]
- [2]Health Canada (DPD) · 00711306 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.